University at Buffalo - The State University of New York
Skip to Content
Renuka                         Iyer

Renuka Iyer MD

Department of Medicine

Clinical Assistant Professor

Specialty/Research Focus

Internal Medicine; Medical Oncology; Oncology

 

Education and Training:
  • Fellowship, Medical Oncology, Roswell Park Cancer Institute (2004)
  • Residency, Internal Medicine, Cornell University School of Medicine (2001)
  • Postdoctoral Associate, Internal Medicine, Fox Chase Center (1998)
  • MBBS, Internal Medicine, University of Bombay (1995)
Employment:
  • Associate Professor of Medicine, Oncology, University at Buffalo (2012-present)
  • Associate Professor of Oncology, Medicine, Roswell Park Cancer Institute (2011-present)
  • Assistant Professor of Medicine, Medicine, University at Buffalo (2004–2012)
  • Assistant Professor of Oncology, Medicine, Roswell Park Cancer Institute (2044–2011)
Awards and Honors:
  • DELPHI Neuroendocrine Tumor Panelist (2011)
  • Invited R01 Grant Application Reviewer, NIAID/NIH/DHHS (2010)
  • Best Teacher Award, Roswell Park Oncology Fellows (2008)
  • American Cancer Society Mentored Research Scholar Award (2008)
  • Thomas Frawley Resient Research Fellowship, UB (2003)
  • Junior Investigator Award, Conference on Chemical Modifiers in Cancer Treat (1997)
  • Distinction in Pharmacology, University of Bombay (1990)

Grants and Sponsored Research:
  • January 2008–December 2012
    Targeted Therapies in Hepatocellular Cancer.
    ACS
    Role: Principal Investigator
  • April 2007–December 2009
    Pre-clinical Evaluation of the Efficacy and Anti-angiogenic Effects of Sunitinib on Hepatocellular Carcinoma (HCC) in the Woodchuck Model of Hepatitis B related HCC.
    Roswell Park Alliance Foundation
    Role: Principal Investigator
  • July 2005–June 2009
    Open Label Study of Capecitabine, Gemcitabine and Bevacizumab in Pancreatic Cancer: A Phase II Study with Biologic Correlates
    NCCN
    Role: Principal Investigator
  • July 2005
    Capecitabine in Combination with Oxaliplatin and Radiation: A Phase II Neoadjuvant Study for Esophageal Cancer
    NCCN
    Role: Co-Investigator


Professional Memberships:
  • Carcinoid.org NET Physician/Expert (2010–present)
  • American Association for the Study of Liver Diseases (2010–present)
  • American College of Gastroenterology (2009–present)
  • American College of Surgeons Oncology Group (2004–present)
  • American Association for Cancer Research (2004–present)
  • American Society of Clinical Oncology (2001–present)
  • Radiation Research Society, Student Member (1998–2001)
  • Maharashtra Medical Council, India (1989–present)

School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (716) 845-3099
Email: riyer@buffalo.edu


Log in to Update Your Profile